Search Results 1581-1590 of 19451 for hemoglobin

1. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

   Hemoglobin >= 8 g/dL (may be supported). Patients with a known seizure disorder should be stable and should not have experienced a significant increase in ...

2. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

   ... hemoglobin ≥ 80 g/L; if presence of bone marrow infiltration, neutrophil count ≥ 1.0 × 10^9 /L and platelet count ≥ 50× 10^9 /L. Adequate renal function ...

3. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   Hemoglobin concentration ≥ 9 g/dL;; White blood cells ≥ 2000/mm^3. Liver function: Total bilirubin ≤1.5 × the upper limit of normal (ULN) with the ...

4. Hematology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

5. A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP) - Mayo Clinic

   * Blood counts at screening: Hemoglobin ≥9.0 g/dL (participant must not have received blood transfusion within 7 days prior to sample being taken); ...

6. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   * Hemoglobin \>= 8.0 g/dL. * Total bilirubin =\< 1.5 x upper limit of normal (ULN) (obtained =\< 14 days prior to registration). * Alanine transaminase (ALT) ...

7. Mayo Clinic Biobank - Other Health Conditions

   D., is researching bilirubin metabolism. Bilirubin is the breakdown product of hemoglobin in the liver and acts as a diagnostic marker for different liver and ...

8. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

9. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

10. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    Hemoglobin ≥ 8 g/dL or ≥ 5 mmol/L;; Alanine aminotransferase (ALT), aspartate aminotransferase (AST) ≤ 3 x upper limit of normal (ULN) and total bilirubin ...